Journal article
Effect of Candesartan on Cause-Specific Mortality in Heart Failure Patients
Abstract
BACKGROUND: Patients with heart failure are at increased risk of sudden death and death attributed to progressive pump failure. We assessed the effect of candesartan on cause-specific mortality in patients enrolled in the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program.
METHODS AND RESULTS: The CHARM program consisted of 3 component trials that enrolled patients with symptomatic heart failure: …
Authors
Solomon SD; Wang D; Finn P; Skali H; Zornoff L; McMurray JJV; Swedberg K; Yusuf S; Granger CB; Michelson EL
Journal
Circulation, Vol. 110, No. 15, pp. 2180–2183
Publisher
Wolters Kluwer
Publication Date
October 12, 2004
DOI
10.1161/01.cir.0000144474.65922.aa
ISSN
0009-7322
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedAngiotensin II Type 1 Receptor BlockersBenzimidazolesBiphenyl CompoundsCanadaCardiovascular DiseasesCause of DeathDeath, Sudden, CardiacDisease ProgressionFemaleHeart FailureHumansMaleMiddle AgedProportional Hazards ModelsSingle-Blind MethodSwedenTetrazolesUnited KingdomUnited StatesVentricular Dysfunction, Left